In this study, we reveal a previously unknown non-oncogene addiction to the PML gene in ccRCC by finding that PML is overexpressed in this tumor and that its genetic or pharmacologic inhibition triggers tumor-suppressive responses of cellular senescence and p53 induction. This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.